Denali Capital Acquisition said $50,000 was deposited into its trust to extend the SPACs completion deadline to March 11, following shareholder approval in January of a merger with Longevity Biomedical.
Redemptions have removed most of the SPACs trust, although Longevity Biomedical in August agreed to waive the deals $30 million cash closing condition.
Longevity is focused on advancing new technologies across therapeutics, health monitoring and digital health solutions to increase human health span. Read more.
View original post here:
Denali Capital Pumps Another $50K into Trust for Additional Month to Close Longevity Deal | DealFlow's SPAC News - DealFlow's SPAC News
Recommendation and review posted by G. Smith
